Sign In
Buy GSK
$51.46
-0.0700 (-0.136%)
At Close: Aug 05, 2026
GSK Gets CHMP Nod for Expanded Use of HIV Combo & Jemperli
11:46am, Tuesday, 17'th Dec 2024
The CHMP recommends marketing approval to GSK's Vocabria plus JNJ's Rekambys for treating HIV-1 infection in adolescents aged 12 years and older.
GSK passes three significant milestones with new cancer drug given a double boost
03:21am, Monday, 16'th Dec 2024
GSK PLC (LSE:GSK, NYSE:GSK) has announced significant progress in its oncology pipeline, achieving three milestones. The European Medicines Agency (EMA) has issued a positive opinion recommending the
GSK Stock Declines 20% in 3 Months: Should You Buy, Sell or Hold?
11:21am, Wednesday, 11'th Dec 2024
Though GSK is definitely not the best large-cap drugmaker to have in one's portfolio, we believe there is potential for its sales and profits to improve.
Relation announces two strategic collaborations with GSK to advance therapeutics for fibrotic diseases and osteoarthritis
07:00am, Tuesday, 10'th Dec 2024
FOR IMMEDIATE RELEASE Relation announces two strategic collaborations with GSK to advance therapeutics for fibrotic diseases and osteoarthritis
Relation announces two strategic collaborations with GSK to advance therapeutics for fibrotic diseases and osteoarthritis
02:00am, Tuesday, 10'th Dec 2024
Relation announces two strategic collaborations with GSK to advance therapeutics for fibrotic diseases and osteoarthritis London, UK, December 10, 2024 – Relation, an industry leader in deploying co
GSK says blood cancer drug shows dramatic survival gains in key trial
02:46pm, Monday, 09'th Dec 2024
GSK PLC (LSE:GSK, NYSE:GSK) shares in New York rose Monday afternoon after it announced that its blood cancer drug Blenrep (belantamab mafodotin) significantly extended survival in a pivotal trial. Th
GSK's drug combo shown to cut risk of death by 42% in type of blood cancer
01:37pm, Monday, 09'th Dec 2024
British drugmaker GSK said on Monday its experimental cancer drug Blenrep in combination with other treatments reduced the risk of death by 42% in multiple myeloma, a common type of blood cancer, at o
FDA Accepts GSK's Filing for Expanded Use of Nucala in COPD
12:30pm, Monday, 09'th Dec 2024
The FDA accepts GSK's regulatory filing seeking the expanded use of Nucala in COPD treatment for review.
Final Trades: Oracle, Vertiv Holdings and GSK
01:28pm, Friday, 06'th Dec 2024
The Investment Committee give you their top stocks to watch for the second half.
GSK Expands Vaccine Collaboration With Zhifei in China
12:55pm, Thursday, 05'th Dec 2024
GSK expands the licensing deal with Zhifei to market its shingles vaccine in China for an additional eight years till 2034.
GSK extends vaccine partnership with Zhifei in China
03:51am, Thursday, 05'th Dec 2024
GSK PLC (LSE:GSK, NYSE:GSK) has extended its partnership with Chongqing Zhifei Biological Products (Zhifei) to bring its shingles vaccine, Shingrix, to mainland China through 2034. The revised agreeme
GSK, China's Zhifei Expand Shingles Shot Collaboration
03:40am, Thursday, 05'th Dec 2024
GSK extended its collaboration with Zhifei to commercialize its shingles vaccine Shingrix in China until 2034.
GSK expands deal with China's Zhifei to explore RSV vaccine collaboration
02:29am, Thursday, 05'th Dec 2024
GSK said on Thursday it has expanded its agreement with China's Zhifei to explore a collaboration with the Chinese vaccines company on the British drugmaker's respiratory syncytial virus (RSV) vaccine
GSK Gets EC Nod for Liquid Version of Meningococcal Vaccine Menveo
11:26am, Thursday, 28'th Nov 2024
The European Commission approves fully liquid presentation of GSK's meningococcal vaccine, Menveo, to protect against invasive meningococcal disease.
Anson Resources unique chemical-free lithium brine pre-treatment used in successful DLE testing
06:45am, Wednesday, 27'th Nov 2024
Anson Resources Ltd (ASX:ASN, OTCQB:ANSNF) has successfully tested its chemical-free lithium brine pre-treatment process that reduces iron in brine, with the iron-free brine successfully used as feed
